Chalcones, or 1,3-diphenyl-2-propene-1-ones (Figure 1B), are in the class of agents that have shown a promising therapeutic efficacy against several types of cancer and also display characteristics of an EGFR inhibitor [14,15,16]. Here, EGFR is linked to cancer.